Thursday, June 27, 2019 4:09:59 PM
RMS Medical Products Receives Favorable Court Ruling
CHESTER, N.Y.--(BUSINESS WIRE)-- Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS Medical” or “the Company”) today announced that on June 24, 2019 the United States District Court for the Eastern District of Texas (Case No. 2:15-CV-01167-JRG-RSP) issued a decision recommending that RMS Medical’s motion for summary judgement of non-infringement against EMED Technologies (“EMED”) be granted and that the case before it be dismissed.
As previously reported, on June 25, 2015 EMED filed a case in the United States District Court for the Eastern District of Texas claiming patent infringement on one of its patents by the Company’s needle sets and seeking unspecified monetary damages. This case is one of several pending between RMS Medical and EMED.
On June 26, 2019, EMED filed objections to the decision.
The decision of the Magistrate Judge serving in the United States District Court for the Eastern District of Texas, EMED’s objections and associated documents will be reviewed by the District Judge. RMS Medical believes it will prevail on the merits and the District Judge will uphold the decision of the Magistrate Judge and dismiss the case, although there can be no assurances.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM